Sökning: "Parkinson’s disease"
Visar resultat 11 - 15 av 432 avhandlingar innehållade orden Parkinson’s disease.
11. A Systems Biological Approach to Parkinson's Disease
Sammanfattning : Parkinson’s Disease (PD) is the second most common neurodegenerative disease in the Western world. Itshows a high degree of genetic and phenotypic complexity with many implicated factors, various diseasemanifestations but few clear causal links. Ongoing research has identified a growing number of molecularalterations linked to the disease. LÄS MER
12. Automating levodopa dosing schedules for Parkinson’s disease
Sammanfattning : Parkinson’s disease (PD) is the second most common neurodegenerative disease. Levodopa is mainly used to manage the motor symptoms of PD. However, disease progression and long-term use of levodopa cause reduced medication efficacy and side effects. When that happens, precise individualized dosing schedules are required. LÄS MER
13. Intestinal transport of levodopa : Implications for the therapy of Parkinson's disease
Sammanfattning : Levodopa has been the basic treatment of patients with Parkinson's disease for the last 30 years. However, with time nearly all patients develop fluctuations in motor performance correlated to levodopa plasma concentrations. LÄS MER
14. Studies on the Etiology of Parkinson's disease
Sammanfattning : ABSTRACT Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world and affects around 1% of the population over 60 years of age. The main symptoms of PD include bradykinesia, resting tremor and rigidity, caused to a large extent by degeneration of the dopaminergic neurons in substantia nigra. LÄS MER
15. Pharmacotherapy for Parkinson's Disease - Observations and Innovations
Sammanfattning : Pharmacotherapy for Parkinson’s disease (PD) is based on levodopa, the most effective dopaminergic drug. The development of motor complications constitutes the major challenge for new or refined therapies. LÄS MER